MEDIOLANUM Trademark

Trademark Overview

On Monday, February 25, 2013, a trademark application was filed for MEDIOLANUM with the United States Patent and Trademark Office. The USPTO has given the MEDIOLANUM trademark a serial number of 79129272. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, January 28, 2023. This trademark is owned by MEDIOLANUM FARMACEUTICI S.P.A.. The MEDIOLANUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in haematology, in oncology in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-bases disease, antivirals, anti-biotics, antifungals, vaccines
mediolanum

General Information

Serial Number79129272
Word MarkMEDIOLANUM
Filing DateMonday, February 25, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, January 28, 2023
Registration Number4523866
Registration DateTuesday, May 6, 2014
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in haematology, in oncology in transplantation, in ophthalmology, for use in the gastroenterological areas and the prevention and treatment of ocular disorders or diseases, anti-infectives, pharmaceutical preparations treating bacterial-bases disease, antivirals, anti-biotics, antifungals, vaccines
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMEDIOLANUM FARMACEUTICI S.P.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressI-20143 MILANO
IT
Party NameMEDIOLANUM FARMACEUTICI S.P.A.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressI-20143 MILANO
IT
Party NameMEDIOLANUM FARMACEUTICI S.P.A.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressI-20143 MILANO
IT

Trademark Events

Event DateEvent Description
Saturday, August 26, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, August 26, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, March 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 12, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, February 12, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 11, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Friday, January 24, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 24, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 6, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 3, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 17, 2014FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, September 17, 2014FINAL DISPOSITION PROCESSED
Wednesday, August 6, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 6, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2014NOTIFICATION PROCESSED BY IB
Tuesday, February 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 29, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 11, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, January 11, 2014ASSIGNED TO LIE
Saturday, December 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 12, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 12, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 6, 2013REFUSAL PROCESSED BY IB
Monday, June 17, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, June 17, 2013REFUSAL PROCESSED BY MPU
Sunday, June 16, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, June 15, 2013NON-FINAL ACTION WRITTEN
Monday, June 10, 2013ASSIGNED TO EXAMINER
Friday, May 17, 2013APPLICATION FILING RECEIPT MAILED
Monday, May 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 9, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

mediolanum system disorders treatment pharmaceutical anti preparations diseases prevention infectives treating